These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38822857)

  • 1. Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation.
    Siblany L; Stocker N; Ricard L; Brissot E; Duléry R; Banet A; Sestili S; Belhocine R; Van de Wyngaert Z; Bonnin A; Capes A; Ledraa T; Beurier P; Fadel K; Mohty M; Gaugler B; Malard F
    J Clin Immunol; 2024 Jun; 44(6):139. PubMed ID: 38822857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower incidence of grade II-IV acute Graft-versus-Host-Disease in pediatric patients recovering with high Vδ2+ T cells after allogeneic stem cell transplantation with unmanipulated bone marrow grafts: a prospective single-center cohort study.
    Müller T; Alasfar L; Preuß F; Zimmermann L; Streitz M; Hundsdörfer P; Eggert A; Schulte J; von Stackelberg A; Oevermann L
    Front Immunol; 2024; 15():1433785. PubMed ID: 39136029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
    Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
    Front Immunol; 2019; 10():1997. PubMed ID: 31507601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT.
    Andrlová H; Miltiadous O; Kousa AI; Dai A; DeWolf S; Violante S; Park HY; Janaki-Raman S; Gardner R; El Daker S; Slingerland J; Giardina P; Clurman A; Gomes ALC; Nguyen C; da Silva MB; Armijo GK; Lee N; Zappasodi R; Chaligne R; Masilionis I; Fontana E; Ponce D; Cho C; Bush A; Hill L; Chao N; Sung AD; Giralt S; Vidal EH; Hosszu KK; Devlin SM; Peled JU; Cross JR; Perales MA; Godfrey DI; van den Brink MRM; Markey KA
    Sci Transl Med; 2022 May; 14(646):eabj2829. PubMed ID: 35613281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Kawaguchi K; Umeda K; Hiejima E; Iwai A; Mikami M; Nodomi S; Saida S; Kato I; Hiramatsu H; Yasumi T; Nishikomori R; Kondo T; Takaori-Kondo A; Heike T; Adachi S
    Int J Hematol; 2018 Jul; 108(1):66-75. PubMed ID: 29582333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vδ2
    Wragg KM; Tan HX; Kristensen AB; Nguyen-Robertson CV; Kelleher AD; Parsons MS; Wheatley AK; Berzins SP; Pellicci DG; Kent SJ; Juno JA
    Cell Rep; 2020 Jun; 31(11):107773. PubMed ID: 32553157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique and Common Features of Innate-Like Human Vδ2
    Provine NM; Binder B; FitzPatrick MEB; Schuch A; Garner LC; Williamson KD; van Wilgenburg B; Thimme R; Klenerman P; Hofmann M
    Front Immunol; 2018; 9():756. PubMed ID: 29740432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of effector memory Vδ2
    Huang Y; Jiang C; Zhu J; Lin L; Mao M; Yin T; Cai G
    Front Immunol; 2024; 15():1397483. PubMed ID: 38915409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation.
    Solders M; Erkers T; Gorchs L; Poiret T; Remberger M; Magalhaes I; Kaipe H
    Front Immunol; 2017; 8():1861. PubMed ID: 29312341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of Circulating Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation: Its Association with the Riboflavin Synthetic Pathway of Gut Microbiota in Cord Blood Transplant Recipients.
    Konuma T; Kohara C; Watanabe E; Takahashi S; Ozawa G; Suzuki K; Mizukami M; Nagai E; Jimbo K; Kaito Y; Isobe M; Kato S; Takahashi S; Chiba A; Miyake S; Tojo A
    J Immunol; 2020 Mar; 204(6):1462-1473. PubMed ID: 32041784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human blood MAIT cell subsets defined using MR1 tetramers.
    Gherardin NA; Souter MN; Koay HF; Mangas KM; Seemann T; Stinear TP; Eckle SB; Berzins SP; d'Udekem Y; Konstantinov IE; Fairlie DP; Ritchie DS; Neeson PJ; Pellicci DG; Uldrich AP; McCluskey J; Godfrey DI
    Immunol Cell Biol; 2018 May; 96(5):507-525. PubMed ID: 29437263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic Cells Are Critical for the Activation and Expansion of Vδ2
    Wang X; Liu J; Gao H; Mo XD; Han T; Xu LP; Zhang XH; Huang XJ
    Front Immunol; 2018; 9():2528. PubMed ID: 30443256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation.
    Bhattacharyya A; Hanafi LA; Sheih A; Golob JL; Srinivasan S; Boeckh MJ; Pergam SA; Mahmood S; Baker KK; Gooley TA; Milano F; Fredricks DN; Riddell SR; Turtle CJ
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):242-251. PubMed ID: 29024803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomes.
    Galaverna F; Flamini S; De Luca CD; Pili I; Boccieri E; Benini F; Quagliarella F; Rosignoli C; Rosichini M; Genah S; Catanoso M; Cardinale A; Volpe G; Coccetti M; Pitisci A; Li Pira G; Carta R; Lucarelli B; Del Bufalo F; Bertaina V; Becilli M; Pagliara D; Algeri M; Merli P; Locatelli F; Velardi E
    Haematologica; 2024 May; ():. PubMed ID: 38813718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
    Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal-associated invariant T cells and Vδ2
    Hannaway RF; Wang X; Schneider M; Slow S; Cowan J; Brockway B; Schofield MR; Morgan XC; Murdoch DR; Ussher JE
    Clin Exp Immunol; 2020 Feb; 199(2):201-215. PubMed ID: 31587268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
    Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
    Front Immunol; 2021; 12():605766. PubMed ID: 34025637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.